You are here

Citizens for Legitimate Government

For the truth you're not being told anywhere else.

CLG Breaking News and Commentary

Click here!

Contribute to CLG

Subscribe to Syndicate

NJ Drug Company Execs Charged With Insider Trading

NJ Drug Company Execs Charged With Insider Trading 19 Nov 2012 Two pharmaceutical company executives are among six people charged in what federal authorities in New Jersey are calling a five-year insider trading scheme. John Lazorchak was director of financial reporting at Celgene Corp. and Mark Cupo held a similar position at Sanofi-Aventis. The U.S. attorney's office in New Jersey says that between 2007 and 2012, Lazorchak and Cupo passed privileged information on their companies' merger and acquisition plans, financial results and regulatory applications to others who would make stock trades.